Literature DB >> 10722478

Concentrations of chloroquine and malaria parasites in blood in Nigerian children.

F P Mockenhaupt1, J May, Y Bergqvist, O G Ademowo, P E Olumese, A G Falusi, L Grossterlinden, C G Meyer, U Bienzle.   

Abstract

Consumption of chloroquine (CQ) and subtherapeutic drug levels in blood are considered to be widespread in areas where malaria is endemic. A cross-sectional study was performed with 405 Nigerian children to assess factors associated with the presence of CQ in blood and to examine correlations of drug levels with malaria parasite species and densities. Infections with Plasmodium species and parasite densities were determined by microscopy and PCR assays. Whole-blood CQ concentrations were measured by high-performance liquid chromatography. Plasmodium falciparum, P. malariae, and P. ovale were observed in 80, 16, and 9% of the children, respectively, and CQ was detected in 52% of the children. CQ concentrations were >17 and <100 nmol/liter in 25% of the children, 100 to 499 nmol/liter in 14% of the children, and > or =500 nmol/liter in 13% of the children. Young age, attendance at health posts, and absence of parasitemia were factors independently associated with CQ in blood. With increasing concentrations of CQ, the prevalence of P. falciparum infection and parasite densities decreased. However, at concentrations corresponding to those usually attained during regular prophylaxis (> or =500 nmol/liter), 62% of children were still harboring P. falciparum parasites. In contrast, no infection with P. malariae and only one infection with P. ovale were observed in children with CQ concentrations of > or =100 nmol/liter. These data show the high prevalence of subcurative CQ concentrations in Nigerian children and confirm the considerable degree of CQ resistance in that country. Subtherapeutic drug levels are likely to further promote CQ resistance and may impair the development and maintenance of premunition in areas where malaria is endemic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722478      PMCID: PMC89779          DOI: 10.1128/AAC.44.4.835-839.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Effect of iron supplementation and malaria prophylaxis in infants on Plasmodium falciparum genotypes and multiplicity of infection.

Authors:  H P Beck; I Felger; P Vounatsou; R Hirt; M Tanner; P Alonso; C Menendez
Journal:  Trans R Soc Trop Med Hyg       Date:  1999-02       Impact factor: 2.184

2.  Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study.

Authors:  F al-Yaman; B Genton; J C Reeder; R F Anders; T Smith; M P Alpers
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Sep-Oct       Impact factor: 2.184

3.  The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis.

Authors:  J C Wetsteyn; P J De Vries; B Oosterhuis; C J Van Boxtel
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

4.  High rate of mixed and subpatent malarial infections in southwest Nigeria.

Authors:  J May; F P Mockenhaupt; O G Ademowo; A G Falusi; P E Olumese; U Bienzle; C G Meyer
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

5.  Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance.

Authors:  C V Plowe; A Djimde; T E Wellems; S Diop; B Kouriba; O K Doumbo
Journal:  Am J Trop Med Hyg       Date:  1996-11       Impact factor: 2.345

6.  Chloroquine excretion following malaria prophylaxis.

Authors:  L L Gustafsson; B Lindström; A Grahnén; G Alván
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

7.  High incidence of malaria in alpha-thalassaemic children.

Authors:  T N Williams; K Maitland; S Bennett; M Ganczakowski; T E Peto; C I Newbold; D K Bowden; D J Weatherall; J B Clegg
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

8.  Economic prospects for a new antimalarial drug.

Authors:  S Foster
Journal:  Trans R Soc Trop Med Hyg       Date:  1994-06       Impact factor: 2.184

9.  The development and spread of drug-resistant malaria.

Authors:  W H Wernsdorfer
Journal:  Parasitol Today       Date:  1991-11

10.  Studies on Plasmodium falciparum in continuous cultivation. I. The effect of chloroquine and pyrimethamine on parasite growth and viability.

Authors:  W H Richards; B K Maples
Journal:  Ann Trop Med Parasitol       Date:  1979-04
View more
  9 in total

Review 1.  Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.

Authors:  Rajeev K Mehlotra; Cara N Henry-Halldin; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

Review 2.  Plasmodium malariae and Plasmodium ovale--the "bashful" malaria parasites.

Authors:  Ivo Mueller; Peter A Zimmerman; John C Reeder
Journal:  Trends Parasitol       Date:  2007-04-24

Review 3.  Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread.

Authors:  E Y Klein
Journal:  Int J Antimicrob Agents       Date:  2013-02-08       Impact factor: 5.283

4.  Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria.

Authors:  Arletta Añez; Manuel Moscoso; Cecilia Garnica; Carlos Ascaso
Journal:  Malar J       Date:  2016-07-19       Impact factor: 2.979

5.  Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania.

Authors:  Joanna Gallay; Emilie Pothin; Dominic Mosha; Erick Lutahakana; Festo Mazuguni; Martin Zuakulu; Laurent Arthur Decosterd; Blaise Genton
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

6.  Antimalarial drugs impact chemical messenger secretion by blood platelets.

Authors:  Kang Xiong-Hang; Jiayi He; Kaila Kemnetz-Ness; Christy Haynes
Journal:  Biochem Biophys Rep       Date:  2020-04-22

7.  Revisiting the Effect of Pharmaceuticals on Transmission Stage Formation in the Malaria Parasite Plasmodium falciparum.

Authors:  Basil T Thommen; Armin Passecker; Tamara Buser; Eva Hitz; Till S Voss; Nicolas M B Brancucci
Journal:  Front Cell Infect Microbiol       Date:  2022-02-11       Impact factor: 5.293

8.  Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance.

Authors:  Eva Maria Hodel; Abdunoor Mulokozi Kabanywanyi; Aggrey Malila; Boris Zanolari; Thomas Mercier; Hans-Peter Beck; Thierry Buclin; Piero Olliaro; Laurent Arthur Decosterd; Blaise Genton
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

9.  Antimalarial drug use in general populations of tropical Africa.

Authors:  Florence Gardella; Serge Assi; Fabrice Simon; Hervé Bogreau; Teunis Eggelte; Fatou Ba; Vincent Foumane; Marie-Claire Henry; Pélagie Traore Kientega; Léonardo Basco; Jean-François Trape; Richard Lalou; Maryse Martelloni; Marc Desbordes; Meïli Baragatti; Sébastien Briolant; Lionel Almeras; Bruno Pradines; Thierry Fusai; Christophe Rogier
Journal:  Malar J       Date:  2008-07-08       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.